Formulation Development and Primary Degradation Pathways for Recombinant Human Nerve Growth Factor-Reference-Cited by-同舟云学术

Formulation Development and Primary Degradation Pathways for Recombinant Human Nerve Growth Factor

Published:1997-10-01 Issue:20 Volume:69 Page:4184-4190
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Eng Marian¹,Ling Victor¹,Briggs Jonathan A.¹,Souza Karen¹,Canova-Davis Eleanor¹,Powell Michael F.¹,De Young Linda R.¹

Affiliation:

1. Department of Medicinal and Analytical Chemistry and Department of Pharmaceutical Research and Development, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ac9704016

Reference24 articles.

1. Neurotrophic factor therapy for nervous system degenerative diseases

2. The Nerve Growth Factor 35 Years Later

3. Nerve growth factor prevents experimental cisplatin neuropathy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A combinatorial approach for spinal cord injury repair using multifunctional collagen-based matrices: development, characterization and impact on cell adhesion and axonal growth;Biomedical Materials;2020-07-31

2. Facile design of autogenous stimuli-responsive chitosan/hyaluronic acid nanoparticles for efficient small molecules to protein delivery;Journal of Materials Chemistry B;2020

3. Chapter 9: Leveraging the Multi-attribute Method (MAM) to Improve Biotherapeutic Development;Development of Biopharmaceutical Drug-Device Products;2020

4. Designing a Novel Drug Delivering Nerve Guide: A Preliminary Study;Journal of Medical and Biological Engineering;2018-04-09

5. Rational Design of Liquid Formulations of Proteins;Therapeutic Proteins and Peptides;2018